Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-14
1985-11-12
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549306, C07D30793, A61K 31365
Patent
active
045528950
ABSTRACT:
The invention provides for certain compounds derived from ascorbic acid and their formulations which are useful in inhibiting angiogenesis in mammals.
REFERENCES:
patent: 3734929 (1973-05-01), Robinson
patent: 4208434 (1980-06-01), Iacobucci et al.
patent: 4231939 (1980-11-01), Hartzler
patent: 4329290 (1982-05-01), Sawyer et al.
patent: 4408061 (1983-10-01), Salzburg et al.
Imai in Chemical Abstracts, 95:90621s.
Shrihatti et al., "Preparation & Properties of 3-Methyl & 2,3-Dimethyl Ethers of Ascorbic Acid", Ind. J. Chem. Sect. B, 15B(9), 861 (1977).
Canadian Journal of Chemistry, 43, 450 (1965).
Experientia, 24 (4), 326 (1968) as abstracted in Chemical Abstracts, 68:111383a.
Acta Cryst., B. 32, 1665 (1976).
J. Am. Chem. Soc., 104, 4497 (1982).
Acta. Chem. Scand., B. 33, 503 (1979).
Chemistry and Industry, 89 (1965).
Barton Russell L.
Briggs Stephen L.
Koppel Gary A.
Ashbrook Charles W.
Eli Lilly and Company
Fan Jane T.
Whale Arthur R.
LandOfFree
Furo[3,2-b]furan-2-(3H)-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Furo[3,2-b]furan-2-(3H)-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Furo[3,2-b]furan-2-(3H)-ones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1880488